In August 2024, the Company announced it had identified an initial list of less than 5% of its total fleet that were not ... financial information presented in accordance with generally accepted ...
No matter how small the risk that Constellation will see its own growth stymied by regulatory interference, the stock currently costs nearly 29 times forecast 2024 earnings of $8 to $8.40 per share.
Quarterly Revenue Growth of 1.9%, driven by continued strong growth in the International segment Quarterly Net Income of $6.4 million, or $0.20 per diluted share Quarterly Adjusted EBITDA (non-GAAP) ...
LOUISVILLE, Colo., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the third quarter ...
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its fi ...